193 related articles for article (PubMed ID: 20600078)
21. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
22. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA.
Olaussen E; Rekvig OP
J Autoimmun; 1999 Aug; 13(1):95-102. PubMed ID: 10441173
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
24. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
[TBL] [Abstract][Full Text] [Related]
27. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.
Copple SS; Sawitzke AD; Wilson AM; Tebo AE; Hill HR
Am J Clin Pathol; 2011 May; 135(5):678-84. PubMed ID: 21502422
[TBL] [Abstract][Full Text] [Related]
29. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
31. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
32. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
Warlow R; Carrano J; Dawkins R
Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies].
Qin X; Tao X; Chen ZJ; Jiang JQ; Xu MH; Li RL; Li TJ; Lin FQ; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):472-5. PubMed ID: 19304528
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigens.
Yi A; Lee CH; Moon HW; Kim H; Hur M; Yun YM
Clin Biochem; 2018 May; 55():75-79. PubMed ID: 29608892
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
[TBL] [Abstract][Full Text] [Related]
36. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
37. Novel method for quantitative ANA measurement using near-infrared imaging.
Peterson LK; Wells D; Shaw L; Velez MG; Harbeck R; Dragone LL
J Immunol Methods; 2009 Sep; 349(1-2):1-8. PubMed ID: 19720064
[TBL] [Abstract][Full Text] [Related]
38. Ineffectiveness of rat liver tissues in the screening of connective tissue disease.
Aziz KA
Saudi Med J; 2004 Apr; 25(4):442-6. PubMed ID: 15083212
[TBL] [Abstract][Full Text] [Related]
39. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
Hoffman IE; Peene I; Veys EM; De Keyser F
Clin Chem; 2002 Dec; 48(12):2171-6. PubMed ID: 12446473
[TBL] [Abstract][Full Text] [Related]
40. [Antinuclear antibodies].
Cabiedes J; Núñez-Álvarez CA
Reumatol Clin; 2010; 6(4):224-30. PubMed ID: 21794718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
